Showing results (211-220 of 242) with videos related to
Sort By:
Pageof 25
Cancer|July 15, 1994
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignanciesE F McClay, P D Braly, S Kirmani, et al.Gynecologic Oncology|September 1, 1994
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancerS Kirmani, P S Braly, E F McClay, et al.British Journal of Cancer|June 9, 1999
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatinB Cenni, H K Kim, G J Bubley, et al.Investigational New Drugs|December 16, 1998
Phase I and pharmacokinetic study of intraperitoneal topotecanS C Plaxe, R D Christen, J O'Quigley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancerK T Robbins, A M Storniolo, C Kerber, et al.American Journal of Clinical Oncology|February 1, 1995
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinomaE F McClay, P D Braly, S Kirmani, et al.Cancer|March 1, 1997
A phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanomaE F McClay, M E McClay, J A Jones, et al.Cancer Research|August 1, 1997
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatinA Nehmé, R Baskaran, S Aebi, et al.British Journal of Cancer|September 1, 1995
Enhancement of drug sensitivity of human malignancies by epidermal growth factorR Kröning, J A Jones, D K Hom, et al.Cancer|September 15, 1993
Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma. A biologically important observationE F Mc Clay, M E Mc Clay, K D Albright, et al.Pageof 25